JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

B1492 PYR-41
2 Citation

Target: Proteasome

Summary: inhibitor of Ubiquitin-Activating Enzyme (E1)
A8696 FIIN-2

Target: FGFR

Summary: Irreversible inhibitor of FGFR

≥31.75 mg/mL
B5879 GSK2879552
1 Citation

Target: LSD

Summary: Novel and irreversible LSD1 inhibitor

insoluble in EtOH; ≥10.14 mg/mL
B1104 AZD-9291
1 Citation

Target: EGFR

Summary: Mutated forms EGFR inhibitor

≥24.98 mg/mL
B1343 Phenoxybenzamine HCl

Summary: Adrenergic receptor antagonist

insoluble in H2O; ≥17.02 mg/mL
A8882 THZ1
12 Citation

Target: Cyclin-Dependent Kinases

Summary: Covalent CDK7 inhibitor,potent and selective

≥28.3 mg/mL
B5602 GGsTop

Summary: γ-glutamyl transpeptidase (GGT) inhibitor, novel and irreversible

<6.63 mg/mL
A8170 Z-FA-FMK

Target: cysteine protease

Summary: Cysteine proteases inhibitor

insoluble in H2O; ≥13.45 mg/mL